PAR 1.79% 28.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-253

  1. 278 Posts.
    lightbulb Created with Sketch. 107
    As many others have commented, the PAR management team appears to have lost a good deal of credibility through a combination of imperfect decision making and less than stellar corporate governance.
    It’s therefore unlikely imo that in the improbable event that a ‘white knight’ can be found who’s willing to ride to our rescue, said knight would want to partner with the existing board. Rather I think they would probably look to acquiring the product and the IP, such as it is, including the patents and the supply agreements with Bene, as cheaply as possible, and then move rapidly to take charge of the company, putting their own people into the key roles, and running it themselves.
    For $1m per annum they could probably find someone quite good to head the thing up.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.005(1.79%)
Mkt cap ! $99.69M
Open High Low Value Volume
28.0¢ 28.5¢ 28.0¢ $5.473K 19.50K

Buyers (Bids)

No. Vol. Price($)
1 5511 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 32821 5
View Market Depth
Last trade - 10.48am 03/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.